Allied Corp. ALID

Company Overview

Allied Corp. (OTCQB: ALID) is a publicly traded cannabis company focused on the production, processing, and commercialization of medical cannabis and cannabinoid-derived products. The company has historically positioned itself within the global pharmaceutical cannabis supply chain, with operations centered on low-cost cultivation and extraction in Latin America, particularly Colombia. Public disclosures and corporate materials describe the company as operating in the regulated medical cannabis and wellness sectors, serving pharmaceutical, medical, and consumer-product channels where cannabis-derived ingredients are legally permitted.

The company’s primary business activities have included cannabis cultivation, extraction, cannabinoid ingredient production, and export-oriented medical cannabis development. Allied Corp. has emphasized cost-efficient production due to Colombia’s climate and agricultural conditions, which management has presented as a competitive advantage relative to North American indoor cultivation markets. Public filings indicate the company evolved from an early-stage cannabis investment and cultivation platform into a vertically integrated operator focused on international medical cannabis opportunities. Some operational and commercial details have varied across filings and investor materials, and certain production-scale claims are difficult to independently verify through publicly available disclosures alone.